These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 15010848

  • 1. Interleukin-2 activated microglia engulf tumor infiltrating T cells in the central nervous system.
    Tamakawa N, Saio M, Suwa T, Ohe N, Yoshimura S, Iwama T, Shinoda J, Sakai N, Takami T.
    Int J Mol Med; 2004 Apr; 13(4):497-503. PubMed ID: 15010848
    [Abstract] [Full Text] [Related]

  • 2. B7.1 immunogene therapy effectively activates CD(4+) tumor-infiltrating lymphocytes in the central nervous system in comparison with B7.2 gene therapy.
    Ando H, Saio M, Ohe N, Tamakawa N, Yu H, Nakayama T, Yoshimura S, Kaku Y, Iwama T, Shinoda J, Sakai N, Takami T.
    Int J Oncol; 2002 Apr; 20(4):807-12. PubMed ID: 11894129
    [Abstract] [Full Text] [Related]

  • 3. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 4. Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.
    Elsässer-Beile U, Rindsfüser M, Grussenmeyer T, Schultze-Seemann W, Wetterauer U.
    Br J Cancer; 2000 Sep; 83(5):637-41. PubMed ID: 10944605
    [Abstract] [Full Text] [Related]

  • 5. Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma.
    Komita H, Homma S, Saotome H, Zeniya M, Ohno T, Toda G.
    J Hepatol; 2006 Nov; 45(5):662-72. PubMed ID: 16935390
    [Abstract] [Full Text] [Related]

  • 6. Differential in situ expansion and gene expression of CD4+ and CD8+ tumor-infiltrating lymphocytes following adoptive immunotherapy in a murine tumor model system.
    Evans R, Duffy TM, Kamdar SJ.
    Eur J Immunol; 1991 Aug; 21(8):1815-9. PubMed ID: 1907916
    [Abstract] [Full Text] [Related]

  • 7. Intratumor gene expression after adoptive immunotherapy in a murine tumor model. Regulation of messenger RNA levels associated with the differential expansion of tumor-infiltrating lymphocytes.
    Evans R, Kamdar SJ, Duffy T, Edison L.
    J Immunol; 1993 Jan 01; 150(1):177-84. PubMed ID: 8417123
    [Abstract] [Full Text] [Related]

  • 8. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.
    Renno T, Krakowski M, Piccirillo C, Lin JY, Owens T.
    J Immunol; 1995 Jan 15; 154(2):944-53. PubMed ID: 7814894
    [Abstract] [Full Text] [Related]

  • 9. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
    Nonaka K, Saio M, Suwa T, Frey AB, Umemura N, Imai H, Ouyang GF, Osada S, Balazs M, Adany R, Kawaguchi Y, Yoshida K, Takami T.
    J Leukoc Biol; 2008 Sep 15; 84(3):679-88. PubMed ID: 18566103
    [Abstract] [Full Text] [Related]

  • 10. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
    Tian JQ, Wang ZP, Rodriguez R, Fu JS, Lu JZ, Ma BL.
    Urology; 2006 May 15; 67(5):1093-8. PubMed ID: 16635513
    [Abstract] [Full Text] [Related]

  • 11. Lack of IL-2 cytokine expression despite Il-2 messenger RNA transcription in tumor-infiltrating lymphocytes in primary human breast carcinoma: selective expression of early activation markers.
    Coventry BJ, Weeks SC, Heckford SE, Sykes PJ, Bradley J, Skinner JM.
    J Immunol; 1996 May 01; 156(9):3486-92. PubMed ID: 8617977
    [Abstract] [Full Text] [Related]

  • 12. Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor.
    Yoshino I, Yano T, Murata M, Ishida T, Sugimachi K, Kimura G, Nomoto K.
    Cancer Res; 1992 Feb 15; 52(4):775-81. PubMed ID: 1737336
    [Abstract] [Full Text] [Related]

  • 13. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
    Whiteside TL, Letessier E, Hirabayashi H, Vitolo D, Bryant J, Barnes L, Snyderman C, Johnson JT, Myers E, Herberman RB.
    Cancer Res; 1993 Dec 01; 53(23):5654-62. PubMed ID: 8242620
    [Abstract] [Full Text] [Related]

  • 14. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
    Hwang KS, Cho WK, Yoo J, Seong YR, Kim BK, Kim S, Im DS.
    Cancer Gene Ther; 2004 Jun 01; 11(6):397-407. PubMed ID: 15044962
    [Abstract] [Full Text] [Related]

  • 15. In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.
    Hwu P, Yang JC, Cowherd R, Treisman J, Shafer GE, Eshhar Z, Rosenberg SA.
    Cancer Res; 1995 Aug 01; 55(15):3369-73. PubMed ID: 7614473
    [Abstract] [Full Text] [Related]

  • 16. The therapeutic efficacy of murine anti-tumor T cells: freshly isolated T cells are more therapeutic than T cells expanded in vitro.
    Evans R, Kamdar SJ, Duffy TM, Krupke DM, Fuller JA, Dudley ME.
    Anticancer Res; 1995 Aug 01; 15(2):441-7. PubMed ID: 7763019
    [Abstract] [Full Text] [Related]

  • 17. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
    Alexander JP, Kudoh S, Melsop KA, Hamilton TA, Edinger MG, Tubbs RR, Sica D, Tuason L, Klein E, Bukowski RM.
    Cancer Res; 1993 Mar 15; 53(6):1380-7. PubMed ID: 8443817
    [Abstract] [Full Text] [Related]

  • 18. Functional analysis of tumor-infiltrating leukocytes in breast cancer patients.
    Wong PY, Staren ED, Tereshkova N, Braun DP.
    J Surg Res; 1998 Apr 15; 76(1):95-103. PubMed ID: 9695747
    [Abstract] [Full Text] [Related]

  • 19. Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice.
    Zeng HY, Zhu XA, Zhang C, Yang LP, Wu LM, Tso MO.
    Invest Ophthalmol Vis Sci; 2005 Aug 15; 46(8):2992-9. PubMed ID: 16043876
    [Abstract] [Full Text] [Related]

  • 20. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.
    Katou F, Ohtani H, Watanabe Y, Nakayama T, Yoshie O, Hashimoto K.
    Cancer Res; 2007 Dec 01; 67(23):11195-201. PubMed ID: 18056444
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.